Eloxx

Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.

Business Model:

Revenue: $3.6M

Employees: 11-50

Detailed Eloxx Information

Geographic Data

Eloxx headquarters map

Address: 480 Arsenal Way

City: Watertown

State: MA

Zip: 02472

Country: US

Financial Info

Stage:

grant

Raised Last:

$16M

Raised Total:

$90M

Metrics

8,173,234Website Global Rank

368Website Monthly Traffic

Twitter Followers

Description

Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.

Contact Phone:
+17815775300

Contact Email:

Eloxx went public on 4/26/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/26/2018

Ticker Symbol:
ELOX

IPO Price:
$9.75/share

Amount Raised:
$50M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2017 Series C 5 $30M Catalyst Fund LP
Phillip Frost
Pontifax
GF Securities
Quark Venture
Catalyst Fund LP
Phillip Frost
Pontifax
11/2013 Venture Round -
8/2019 Post-IPO Equity 1 $2.3M Cybele Holdings
Cybele Holdings
5/2021 Post-IPO Equity $51.8M
10/2021 Post-IPO Debt 1 $30M Hercules Capital
Hercules Capital
11/2013 Equity -
8/2017 Series C $0 Korea Investment Partners
Quark Venture
Pontifax
LSP BioVentures
Catalyst Venture Partners
LSP BioVentures
OPKO Health
Phillip Frost
DSC Investment
Korea Investment Partners
Quark Venture
Pontifax
LSP BioVentures
Catalyst Venture Partners
LSP BioVentures
OPKO Health
Phillip Frost
DSC Investment
5/2021 Grant 1 $2.6M Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
3/2022 Grant $0 Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
9/2019 Grant 1 $1.6M Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
1/2021 Grant 1 $2M Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
8/2017 Series C 8 $8M Life Sciences Partners
Pontifax Venture Capital
OPKO Health, Inc.
Quark Venture
Catalyst Fund
DSC Funds
Korea Investment Partners
Korea Investment Partners
Quark Venture
Pontifax
LSP BioVentures
Catalyst Venture Partners
LSP BioVentures
11/2013 Equity - Roche
Pontifax Venture Capital
Roche
Pontifax Venture Capital
3/2022 Grant 1 $15.9M Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
11/2013 Venture Round -
Announced Date Name Price
4/2021 Zikani Therapeutics
6/2017 Sevion Therapeutics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research